Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trial - Wu, YL; Lu, S; Cheng, Y (J Thorac Oncol, 2019)